ATE362983T1 - Menschlicher lysophosphatidsäure rezeptor und dessen verwendung - Google Patents

Menschlicher lysophosphatidsäure rezeptor und dessen verwendung

Info

Publication number: ATE362983T1
Authority: AT; Austria
Prior art keywords: human; receptor; lysophosphatidic acid; human lpa; acid receptor
Prior art date: 1997-11-11

Application number

AT98951754T

Other languages

English (en)

Inventor

Daikichi Fukushima

Shinji Nakade

Hisanori Haga

Original Assignee

Ono Pharmaceutical Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-11-11

Filing date

1998-11-10

Publication date

2007-06-15

1998-11-10 Application filed by Ono Pharmaceutical Co filed Critical Ono Pharmaceutical Co

2007-06-15 Application granted granted Critical

2007-06-15 Publication of ATE362983T1 publication Critical patent/ATE362983T1/de

Links

102000004137 Lysophosphatidic Acid Receptors Human genes 0.000 title 1
108090000642 Lysophosphatidic Acid Receptors Proteins 0.000 title 1
101000889990 Homo sapiens Apolipoprotein(a) Proteins 0.000 abstract 6
102000045903 human LPA Human genes 0.000 abstract 6
102000005962 receptors Human genes 0.000 abstract 5
108020003175 receptors Proteins 0.000 abstract 5
AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 abstract 2
239000002299 complementary DNA Substances 0.000 abstract 2
239000013604 expression vector Substances 0.000 abstract 2
230000010076 replication Effects 0.000 abstract 2
WRGQSWVCFNIUNZ-GDCKJWNLSA-N 1-oleoyl-sn-glycerol 3-phosphate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)COP(O)(O)=O WRGQSWVCFNIUNZ-GDCKJWNLSA-N 0.000 abstract 1
102000057248 Lipoprotein(a) Human genes 0.000 abstract 1
108010033266 Lipoprotein(a) Proteins 0.000 abstract 1
239000000556 agonist Substances 0.000 abstract 1
239000005557 antagonist Substances 0.000 abstract 1
239000003112 inhibitor Substances 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
238000012216 screening Methods 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Zoology (AREA)
Genetics & Genomics (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biochemistry (AREA)
Biophysics (AREA)
General Health & Medical Sciences (AREA)
Toxicology (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
Immunology (AREA)
Cell Biology (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

AT98951754T 1997-11-11 1998-11-10 Menschlicher lysophosphatidsäure rezeptor und dessen verwendung ATE362983T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP30774997		1997-11-11

Publications (1)

Publication Number	Publication Date
ATE362983T1 true ATE362983T1 (de)	2007-06-15

Family

ID=17972816

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT98951754T ATE362983T1 (de)	1997-11-11	1998-11-10	Menschlicher lysophosphatidsäure rezeptor und dessen verwendung

Country Status (7)

Country	Link
US (1)	US6252056B1 (de)
EP (1)	EP1029916B1 (de)
JP (1)	JP4280886B2 (de)
KR (1)	KR100629185B1 (de)
AT (1)	ATE362983T1 (de)
DE (1)	DE69837811D1 (de)
WO (1)	WO1999024569A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6555339B1 (en)	1997-04-14	2003-04-29	Arena Pharmaceuticals, Inc.	Non-endogenous, constitutively activated human protein-coupled receptors
US7119190B2 (en)	1997-04-14	2006-10-10	Arena Pharmaceuticals, Inc.	Endogenous and non-endogenous versions of human G protein-coupled receptors
WO2000022131A2 (en) *	1998-10-13	2000-04-20	Arena Pharmaceuticals, Inc.	Non-endogenous, constitutively activated human g protein-coupled receptors
WO2000031104A1 (en) *	1998-11-19	2000-06-02	Smithkline Beecham Corporation	A novel g-protein coupled 7tm receptor (axor15)
USRE42190E1 (en)	1998-11-20	2011-03-01	Arena Pharmaceuticals, Inc.	Method of identifying a compound for inhibiting or stimulating human G protein-coupled receptors
KR20080104062A (ko) *	1998-11-20	2008-11-28	아레나 파마슈티칼스, 인크.	사람의 오르판 ｇ 단백질 커플링 수용체
US7816492B2 (en)	1998-11-20	2010-10-19	Arena Pharmaceuticals, Inc.	Human G protein-coupled receptors
US20030017528A1 (en)	1998-11-20	2003-01-23	Ruoping Chen	Human orphan G protein-coupled receptors
EP1198569A1 (de) *	1999-07-30	2002-04-24	MERCK PATENT GmbH	An ein g-protein gekoppelter rezeptor und dazugehörige dns
US20030148451A1 (en) *	2000-05-09	2003-08-07	Kevin Bacon	Endothelial differntiation gene 6-like g protein coupled receptor
US6902902B2 (en)	2001-11-27	2005-06-07	Arena Pharmaceuticals, Inc.	Human G protein-coupled receptors and modulators thereof for the treatment of metabolic-related disorders
EP1487965A4 (de)	2002-02-25	2006-11-15	Mpex Pharmaceuticals Inc	Minizellzusammensetzungen und -verfahren
US7300764B2 (en)	2002-06-08	2007-11-27	Sanofi-Aventis Deutschland Gmbh	Method for identifying agonists and antagonists of the GPR45-like/GPR63 receptor
DE10225651A1 (de) *	2002-06-08	2003-12-24	Aventis Pharma Gmbh	Verfahren zur Identifizierung von Agonisten oder Antagonisten für den GPR45like/GPR63 Rezeptor
AU2003289024A1 (en) *	2002-12-12	2004-06-30	Takeda Pharmaceutical Company Limited	Novel use of edg receptors
WO2009089380A2 (en) *	2008-01-08	2009-07-16	The Trustees Of Columbia University In The City Of New York	Methods for p2ry5 mediated regulation of hair growth and mutants thereof
KR101584722B1 (ko) *	2011-09-19	2016-01-13	건국대학교 산학협력단	인삼에서 분리 동정한 당지질단백질 진토닌의 천연 약용식물 유래 리간드로서의 용도

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6210967B1 (en) *	1997-12-10	2001-04-03	Synaptic Pharmaceutical Corporation	DNA encoding a mammalian LPA receptor and uses thereof
WO2000022131A2 (en) *	1998-10-13	2000-04-20	Arena Pharmaceuticals, Inc.	Non-endogenous, constitutively activated human g protein-coupled receptors

1998
- 1998-11-10 WO PCT/JP1998/005047 patent/WO1999024569A1/ja not_active Ceased
- 1998-11-10 AT AT98951754T patent/ATE362983T1/de not_active IP Right Cessation
- 1998-11-10 DE DE69837811T patent/DE69837811D1/de not_active Expired - Lifetime
- 1998-11-10 KR KR1020007005101A patent/KR100629185B1/ko not_active Expired - Fee Related
- 1998-11-10 EP EP98951754A patent/EP1029916B1/de not_active Expired - Lifetime
- 1998-11-10 JP JP2000520564A patent/JP4280886B2/ja not_active Expired - Fee Related
- 1998-11-10 US US09/554,225 patent/US6252056B1/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
KR20010031991A (ko)	2001-04-16
EP1029916B1 (de)	2007-05-23
EP1029916A1 (de)	2000-08-23
KR100629185B1 (ko)	2006-09-28
US6252056B1 (en)	2001-06-26
WO1999024569A1 (fr)	1999-05-20
JP4280886B2 (ja)	2009-06-17
EP1029916A4 (de)	2002-11-13
DE69837811D1 (de)	2007-07-05

Legal Events

Date	Code	Title	Description
2007-11-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
ATE362983T1 (de)	2007-06-15	Menschlicher lysophosphatidsäure rezeptor und dessen verwendung
DE69837707D1 (de)	2007-06-14	Heilmittel für kachexie
WO1999061471A3 (en)	2000-03-16	Human transmembrane proteins
DE69823151D1 (de)	2004-05-19	Toner und Bildherstellungsverfahren unter Verwendung des Toners
ATE175666T1 (de)	1999-01-15	N-(benzofurazanyl)-arylsulfonamide und ihre analoge verwendbar als endothelin-rezeptor- antagonisten
DE68918497D1 (de)	1994-11-03	Monoklonale Mäuseantikörper gegen HIV-IP24 und ihre Verwendung in Diagnostika.
ATE295423T1 (de)	2005-05-15	Phosphodiesterase 8
DE69535274D1 (de)	2006-11-30	Verwendung eines menschlichen interleukin-11 rezeptors
ATE432350T1 (de)	2009-06-15	G-protein gekoppelte rezeptoren
WO2003048305A3 (en)	2004-06-17	Receptors and membrane-associated proteins
PT840620E (pt)	2002-04-29	Antagonistas de il-8 para o tratamento de asma
NO973422D0 (no)	1997-07-24	Recombinant C140-reseptor, dens agonister og antagonister og nukleinsyrer som koder for reseptoren
WO1998055509A3 (en)	1999-03-25	Two human dnaj-like proteins
WO2000003005A3 (en)	2000-03-16	Human checkpoint kinase
WO1999009182A3 (en)	1999-05-20	Rab proteins
WO1998057987A3 (en)	1999-03-18	Irs-p53h, human insulin receptor tyrosine kinase substrate
WO2000003015A3 (en)	2000-04-13	Human transport protein homologs
WO2000008155A3 (en)	2000-06-29	Human receptor-associated proteins
WO2000001821A3 (en)	2000-06-15	Neurotransmission associated proteins
WO1998057986A3 (en)	1999-03-11	Human preprotachykinin b
WO2000018915A3 (en)	2000-07-27	Membrane-associated organizational proteins
WO2000011171A3 (en)	2000-07-27	Human rna-associated proteins
WO2002057454A3 (en)	2004-02-12	Receptors and membrane-associated proteins
WO1999041375A3 (en)	1999-12-16	Human receptor proteins
DK116487A (da)	1987-09-08	Fremgangsmaade til eksponering af en epitop i et protein med bestemt polypeptidstruktur, samt vektorer til brug ved fremgangsmaaden, hybridproteiner omfattende epitopen, og anvendelse af hybridproteinet ved diagnoser.